Haematologica (Aug 2024)
A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
- Hang Quach,
- Gurdeep Parmar,
- Enrique M. Ocio,
- H. Miles Prince,
- Albert Oriol,
- Helen Crowther,
- Nobuhiro Tsukada,
- Pierre Bories,
- Sumit Madan,
- Nitya Nathwani,
- Kazutaka Sunami,
- Dorothee Semiond,
- Disa Yu,
- Paul Cordero,
- Sandrine Macé,
- Florence Suzan,
- Philippe Moreau
Affiliations
- Hang Quach
- Clinical Haematology Service, St Vincent's Hospital, University of Melbourne, Vic, Australia
- Gurdeep Parmar
- Illawarra Cancer Care Centre, Wollongong, NSW, Australia
- Enrique M. Ocio
- Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
- H. Miles Prince
- Molecular Oncology and Cancer Immunology, Epworth Healthcare and University of Melbourne, Melbourne, Vic, Australia
- Albert Oriol
- Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
- Helen Crowther
- Department of Hematology, Blacktown and Mount Druitt Hospitals, Blacktown, NSW, Australia
- Nobuhiro Tsukada
- Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
- Pierre Bories
- Early Phase Unit, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France
- Sumit Madan
- Banner MD Anderson Cancer Center, Gilbert, AZ, USA
- Nitya Nathwani
- Department of Hematology, City of Hope National Medical Center, Duarte, California, USA
- Kazutaka Sunami
- Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan
- Dorothee Semiond
- Sanofi, Research & Development, Cambridge, MA, USA
- Disa Yu
- Sanofi, Research & Development, Cambridge, MA, USA
- Paul Cordero
- Sanofi, Research & Development, Reading, UK
- Sandrine Macé
- Sanofi, Research & Development, Vitry-sur-Seine, France
- Florence Suzan
- Sanofi, Research & Development, Vitry-sur-Seine, France
- Philippe Moreau
- Department of Hematology, University Hospital of Nantes, Nantes, France
- DOI
- https://doi.org/10.3324/haematol.2023.284730
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
